(Q34150474)

31 July 2017

2 references

12 December 2020

2 May 2021

1 reference

1 reference

Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis (English)

1 reference

31 July 2017

1 reference

17 September 2019

1 reference

17 September 2019

2 references

17 September 2019

2 May 2021

1 reference

12 December 2020

1 reference

1 reference

Victoria L Baczek

1

1 reference

31 July 2017

Wendy T Chen

series ordinal

2

1 reference

31 July 2017

Jeffrey Kluger

series ordinal

3

1 reference

31 July 2017

Craig I Coleman

series ordinal

4

1 reference

31 July 2017

language of work or name

1 reference

3 February 2012

8 references

31 July 2017

19 March 2019

22 March 2019

25 April 2019

17 June 2019

17 September 2019

12 December 2020

2 May 2021

8 references

31 July 2017

19 March 2019

22 March 2019

25 April 2019

17 June 2019

17 September 2019

12 December 2020

2 May 2021

13

1 reference

31 July 2017

5

1 reference

Creative Commons Attribution 2.0 Generic

31 July 2017

7 references

19 March 2019

22 March 2019

25 April 2019

17 June 2019

17 September 2019

12 December 2020

on focus list of Wikimedia project

2 May 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2296-13-5

0 references

cites work

Apixaban in patients with atrial fibrillation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Warfarin discontinuation after starting warfarin for atrial fibrillation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Dabigatran versus warfarin in patients with atrial fibrillation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Anticoagulation for patients with atrial fibrillation in ambulatory care settings

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Newly detected atrial fibrillation and compliance with antithrombotic guidelines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Predictors of anticoagulation prescription in nursing home residents with atrial fibrillation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Clinical correlation between effective anticoagulants and risk of stroke: are we using evidence-based strategies?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Is warfarin really underused in patients with atrial fibrillation?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Why do patients with atrial fibrillation not receive warfarin?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Warfarin use among patients with atrial fibrillation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

National patterns of warfarin use in atrial fibrillation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Cost-effectiveness of anticoagulation in nonrheumatic atrial fibrillation in the primary prevention of ischemic stroke.

5 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Predictors of warfarin use in atrial fibrillation patients in the inpatient setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Anticoagulant use for atrial fibrillation in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Differences in quality of care among patients hospitalized with atrial fibrillation as primary or secondary cause for admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Quality of care for atrial fibrillation among patients hospitalized for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Racial disparities in the filling of warfarin prescriptions for nonvalvular atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Temporal trends in the use of anticoagulants among older adults with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Geographic variation in health care and the problem of measuring racial disparities.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3395868

Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention

28 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2296-13-5

Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals

21 January 2018

1 reference

12 December 2020

Recent national patterns of warfarin use in atrial fibrillation

1 reference

12 December 2020

Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission

1 reference

12 December 2020

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2296-13-5

1 reference

Dimensions Publication ID

31 July 2017

1037431209

0 references

Fatcat ID

release_nxw7llchnzbqvh6moeu7zqfuvu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nxw7llchnzbqvh6moeu7zqfuvu

24 November 2022

mapped directly with Wikidata item

PMCID

3395868

1 reference

31 July 2017

1 reference